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Despite decades of intensive research, our understanding of the pathophysiology of 
necrotizing enterocolitis remains poor. The common denominator for development 
of necrotizing enterocolitis in preterm infants seems to be intestinal immaturity. 
This immaturity is believed to lead to decreased circulatory regulation, diminished 
intestinal barrier function, altered microbiota and an impaired immune defense.1–5 
These risk factors can, especially when combined, induce an uncontrolled inflam-
matory cascade in the intestine that causes the clinical signs regularly seen in nec-
rotizing enterocolitis, such as feeding intolerance, abdominal distension, bloody 
stools and, if the disease progresses, intestinal perforation, peritonitis and sepsis.
The course of necrotizing enterocolitis can be highly unpredictable, which 
makes it as yet impossible to foresee which infants are likely to develop a severe 
disease that necessitates surgery or leads to death.2 Surgical procedures in necrotiz-
ing enterocolitis can involve exploratory laparotomy with resection of the necrotic 
bowel followed by the creation of either a primary anastomosis or enterostomy.6,7 
The creation of an enterostomy seems a safe alternative in neonates with an acute 
abdomen undergoing surgery. There is, however, little known about the rate and 
type of complications involved with the creation and closure of an enterostomy.
Due to the fulminant nature of necrotizing enterocolitis, it is unlikely 
that new treatment strategies will provide any major breakthroughs in  reduc-
ing necrotizing enterocolitis-associated mortality and morbidity in  the near 
future.8 Prevention of necrotizing enterocolitis is likely to yield better results and 
improve clinical outcomes for preterm infants.8,9 To prevent the development of 
necrotizing enterocolitis, however, it is essential that we accurately predict which 
neonates are at a high risk of developing the disease.9 Understanding the risk factors 
for necrotizing enterocolitis and identifying indicators that detect these abnormali-
ties early can help us to define markers that aid in the prediction of the disease. As 
the population of affected patients with necrotizing enterocolitis mainly consists of 
vulnerable preterm infants for whom invasive techniques (such as frequent blood 
sampling) are highly undesirable, the ideal marker should be measurable using 
non-invasive methods.10,11
This thesis is about prediction and early diagnostics of necrotizing entero-
colitis, in relation to several non-invasive biomarkers. It also covers various clinical 
aspects. The first aim was to determine noninvasive markers to predict the develop-
ment of necrotizing enterocolitis in asymptomatic preterm infants. The second aim 
was to determine a possible marker that independently predicts the progression of 
necrotizing enterocolitis within the first day after diagnosis. Our third aim, then, 
was to assess the rate and type of complications after the creation and closure of an 
enterostomy in neonates with an acute abdominal emergency in our center.  To this 
end, we formulated the following research questions:
1.  What is known in  the literature about predicting necrotizing enterocolitis 







2.  Can we differentiate high-risk infants who develop necrotizing enterocolitis 
from those who do not by prospectively measuring urinary intestinal fatty 
acid-binding protein? (Chapter 3)
3.  Can serial measurements of fecal calprotectin help us to differentiate high-risk 
infants who develop necrotizing enterocolitis from those who do not? (Chapter 4)
4.  Can serial measurements of fecal bile salts aid in  identifying which preterm 
infants have an increased risk for the development of necrotizing enterocolitis? 
(Chapter 5)
5.  Can cerebral and intestinal oxygenation differentiate high-risk infants who 
develop necrotizing enterocolitis from those who do not? (Chapter 6)
6.  Can conventional laboratory parameters, obtained in an early stage of the dis-
ease, be used to predict the progression of necrotizing enterocolitis? (Chapter 7)
7.  What complications occur after the creation and closure of an enterostomy 
in neonates with an acute abdominal emergency in our center? Is the creation of 
an enterostomy a safe alternative or should it preferably be avoided? (Chapter 8)
General discussion
Many studies in this thesis are part of the prospective CALIFORNIA study, which 
aimed to identify several promising non-invasive markers for necrotizing entero-
colitis.12 These studies could also shed light on the pathophysiology of necroti zing 
enterocolitis, as the markers we tested are all related to different aspects of the 
pathophysiology of the disease. We analyzed markers of intestinal damage, intes-
tinal inflammation, intestinal perfusion and bile salts metabolism respectively for 
their role in  the identification of infants with an increased risk for the develop-
ment of necrotizing enterocolitis. Two of the markers (that of intestinal damage 
and intestinal inflammation) might not be useful (chapter 3, chapter 4), whereas 
the other two (intestinal perfusion and bile salt metabolism) showed more promis-
ing results in the prediction of necrotizing enterocolitis (chapter 5, chapter 6). Our 
main findings are presented in Table 1.
We first investigated a marker for enterocyte damage in  the prediction of 
necrotizing enterocolitis. Urinary intestinal fatty acid-binding protein (iFABPu) 
is among the most commonly studied potential markers for the prediction of 
necrotizing enterocolitis (Chapter 2).13 Given its clear association with intestinal 
145General discussion 
(enterocyte) damage and reports of its potent ability to predict the development 
of necrotizing enterocolitis, iFABP could be considered among the most promis-
ing biomarkers studied so far.13,14 Elevated iFABPu levels during the first days after 
birth were suggested to be the initial sign of mucosal damage that predisposes an 
infant to necrotizing enterocolitis.15,16 In previous studies, such high iFABPu levels 
immediately after birth have been found in infants who subsequently developed the 
disease.15  Furthermore, Gregory et al. suggested that iFABPu is a useful predictor 
of necrotizing enterocolitis within a week (sens. 60%, spec. 78%) and, even more 
strongly, within three days (sens. 65%, spec. 84%) preceding the diagnosis.17 A sen-
sitivity and specificity up to 100% and 96% resp. of iFABPu at the day prior to the 
diagnosis of necrotizing enterocolitis were described by Gollin et al.16
We therefore studied iFABP/cru ratios prospectively and longitudinally 
in a large cohort of high-risk infants. We used iFABP to creatinine ratios (iFABP/
cru) to correct for variations in  kidney function and urine concentration. We 
were surprised that our results contradicted the findings of previous studies. We 
demonstrated clearly that iFABP/cru ratios have no role in the early prediction of 
imminent necrotizing enterocolitis in preterm infants (Chapter 3). That our findings 
contradict earlier literature might, at least partly, be the result of differences in study 
design. Other researchers measured iFABP levels up to the time of the confirmed 
diagnosis of necrotizing enterocolitis.16,17 The confirmation of the diagnosis may 
have been stated at a considerable time after clinical suspicion of necrotizing entero-
colitis arose, explaining why iFABP levels were already elevated in these studies. We 
analyzed the predictive value of iFABP/cru ratios much earlier, until the first clini-
cal symptoms of the disease, which we defined as the first abdominal x-ray within 
the episode of suspected necrotizing enterocolitis. In our cohort, iFABP/cru did not 
differ prior to the onset of symptoms between subjects that developed necrotizing 
enterocolitis and controls. The ratios were, however, significantly higher in subjects 
with necrotizing enterocolitis immediately after the first clinical suspicion of the 
disease had arisen. These findings suggest that necrotizing enterocolitis is a disease 
in which intestinal (enterocyte) damage, detected by an increased level of iFABP, 
rapidly leads to clinical signs.14 But detection of intestinal damage prior to the onset 
of the disease seems therefore not feasible using iFABP measurements in urine. This 
appears to fit the often very acute clinical course of the disease. The low sensitivity 
described in literature of iFABP to predict NEC at respectively 7 and 3 days prior to 























































































































































































































































































































































































































































































































































As necrotizing enterocolitis is an acute inflammatory process, establishing a marker 
for bowel wall inflammation could theoretically be helpful in its prediction or early 
detection.18 Previously, fecal calprotectin had shown high sensitivity and specificity 
to predict moderate necrotizing enterocolitis in a small number of infants within 
one day prior to the onset of the disease (Chapter 2).19 Although these results were 
promising, the effectiveness of using this protein in neonates was still doubted as 
previously high levels and wide interindividual variations in fecal calprotectin were 
observed during the first month of life.20–24 We therefore measured fecal calprotec-
tin serially during the first five weeks after birth in preterm infants at high-risk for 
necrotizing enterocolitis. We found no differences between calprotectin concentra-
tions in subjects who developed necrotizing enterocolitis and controls during the 
week before the first clinical suspicion of the disease. Furthermore, within subjects 
developing necrotizing enterocolitis we did not detect an intra-individual rise 
in  calprotectin concentrations before clinical symptoms of the disease occurred. 
Our results confirmed the previous findings of high concentrations and wide 
interindividual variation in calprotectin.20,22,24–26 Additionally, we observed a wide 
intra-individual variation, which further precludes the use of serial calprotectin 
concentrations in neonatal care in general and, more specifically, in the prediction 
of necrotizing enterocolitis (Chapter 4).
Recently, an aberrant bile salt metabolism has been associated with the 
development of necrotizing enterocolitis.27 The findings of this thesis suggest that 
serial measurements of fecal bile salts levels might be useful in the prediction of 
necrotizing enterocolitis (Chapter 5). We measured unconjugated and conjugated 
fecal bile salts in the first feces sample after birth and in two samples prior to the 
manifestation of necrotizing enterocolitis in ten infants who developed necrotizing 
enterocolitis and in twenty matched controls. We observed that total unconjugated 
bile salt concentrations in  preterm infants that develop necrotizing enterocolitis 
decrease at a  slower rate after birth compared to controls. The level of fecal bile 
salts might be influenced by several factors, such as antibiotic treatment or formula 
feeding.28 Further studies are needed to determine the factors that affect levels of 
fecal bile salts in preterm infants, and whether measuring fecal bile salts has suf-
ficient predictive value and clinical applicability for the development of necrotizing 
enterocolitis. Further research is also necessary to determine whether the levels 
of bile salts are causally related to the development of necrotizing enterocolitis or 
whether altered levels of bile salts are just a bystander effect of other factors that are 
thought to be related to necrotizing enterocolitis e.g. an altered microbiota.29
The last marker that was studied in the CALIFORNIA cohort in this thesis 
focused on perfusion of both the intestines and the brain (Chapter 6). Our findings 







necrotizing enterocolitis. We found that infants with cerebral oxygen saturation 
values below 70 percent (below the 25th percentile) in the first two days after birth 
had a  nine-fold higher risk of developing necrotizing enterocolitis than infants 
with cerebral oxygen saturation above 70 percent (greater than or equal to the 25th 
percentile). Intestinal oxygenation values obtained in the first two days after birth 
were not associated with the development of necrotizing enterocolitis later on. At 2 
days prior to necrotizing enterocolitis, however, intestinal fractional tissue oxygen 
extraction (FTOE) was significantly higher in infants who developed necrotizing 
enterocolitis with infants who did not, indicating that intestinal perfusion may 
have been impaired in the infants developing necrotizing enterocolitis a few days 
later. We were, however, only able to measure intestinal oxygenation values in 23% 
of the infants (Chapter 6), particular during the first week after birth. This small 
sample size may have limited our ability to detect significant differences in intesti-
nal oxygenation values between the two groups. We encountered several practical 
difficulties in monitoring the infra-umbilical region in the first days after birth. On 
the very preterm infants and the infants small for their gestational age space was 
lacking for adequate sensor placement. Furthermore, the presence of an umbilicus 
venous catheter taped to the abdominal skin impeded sensor placement. These 
findings indicate that monitoring at the infra-umbilical region is accompanied with 
practical difficulties in preterm infants in the first days after birth, potentially limit-
ing the usefulness of this measurement procedure in clinical practice.
The clinical presentation of neonates with signs and symptoms that sug-
gest necrotizing enterocolitis can be obscured by similarities to other inflamma-
tory conditions of the newborn.30 Moreover, there are no reliable prognostic signs 
of progressive necrotizing enterocolitis that prelude disease progression prior to 
patients reaching an irreversible state requiring surgery or leading to death.31 We 
assessed, in a 20-year cohort of necrotizing enterocolitis infants, the abilities of con-
ventional laboratory parameters obtained at three different time points during the 
first 24 hours after diagnosis to independently predict the progression of necrotiz-
ing enterocolitis in a large population of patients (Chapter 7). Metabolic acidosis 
(pH < 7.3) and thrombocytopenia were found to be the independent predictors for 
the progression to severe disease.  We concluded, therefore, that acidosis and/or 
thrombocytopenia at onset and during the first 12 to 24 hours after diagnosis of 
necrotizing enterocolitis should alert clinicians to the considerably increased risk 
of progressive disease later on.
In conclusion, the findings in this thesis suggest that necrotizing enterocoli-
tis is a disease in which intestinal damage is almost immediately followed by clinical 
signs. Therefore, markers that detect intestinal damage or intestinal inflammation 
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might not be useful in the early identification of infants who will develop necro-
tizing enterocolitis. The high concentrations and wide inter- and intra-individual 
variation in  fecal calprotectin in  preterm infants during the first weeks of life 
preclude their use to differentiate infants who will develop necrotizing enteroco-
litis from those who will not. Promising results were found for measurements of 
respectively fecal bile salt levels and cerebral and perhaps intestinal oxygenation. 
These markers might be useful in the early identification of preterm infants who 
will develop necrotizing enterocolitis, but further studies are needed to determine 
their precise predictive value and clinical applicability.
While our findings might not have pointed directly towards a new marker 
for the prediction of necrotizing enterocolitis, they did offer insights into the patho-
physiology of necrotizing enterocolitis. Understanding the factors involved in the 
pathophysiology of necrotizing enterocolitis can also help us to identify predictive 
markers in the future.
Pathophysiology
Factors that might be related to the pathophysiology of necrotizing enterocolitis 
in  preterm infants include an impaired intestinal circulation,32–34 intestinal cell 
damage,16,17 intestinal inflammation,2,5 and intestinal bile salt metabolism.27,35 
In Figure 1 we present a schematic overview of the insights into the pathophysiol-
ogy of necrotizing enterocolitis as found in this thesis.
An early postnatal factor that has been associated with the development of 
necrotizing enterocolitis later in life is the presence of impaired intestinal circulation 
during the first days of life.33,36,37 Indications of impaired splanchnic perfusion were 
found in the first days after birth in infants who developed necrotizing enterocolitis 
later on.33 This impaired perfusion might possibly lead to local, subclinical damage 
of the mucosal layer that further predisposes the infant to the later develop ment of 
necrotizing enterocolitis.
In the first two days after birth, we found no differences in intestinal oxygen-
ation values between infants who went on to develop necrotizing enterocolitis and 
controls (Chapter 6). Neither did we observe differences in iFABP/cru ratios between 
the two groups (Chapter 3). These results appear to be in line with each other: as 
no impaired intestinal oxygenation occurred, no ischemic mucosal damage took 
place. Infants who developed necrotizing enterocolitis, however, had lower cerebral 
oxygenation values compared to controls. These findings suggest that the systemic 
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As decreased blood flow to the cerebral tissue usually occurs when compensa-
tory flow redistribution, e.g. reduction of splanchnic circulation, has failed,38 we 
speculate that the splanchnic perfusion also has been affected. The small sample 
size might have led to the absence of significant differences in intestinal oxygen-
ation values between infants who developed necrotizing enterocolitis and controls. 
In line with previous studies we speculate that impaired intestinal circulation that 
occurs early after birth can predispose an infant to the development of necrotizing 
enterocolitis later in life.33,36,37 The direct effect of this impaired circulation on intes-
tinal integrity seems, however, relatively mild since enterocyte damage is not yet 
detectable in  the first week of life. We speculate, therefore, that a  combination 
of several early and late postnatal factors eventually contribute to the development 
of necrotizing enterocolitis and related enterocyte damage (Figure 1).
Beside risk factors early after birth, several factors during the first week(s) 
of life might be related to the development of necrotizing enterocolitis later on. 
Numerous late factors might negatively influence the splanchnic perfusion, includ-
ing anemia,39,40 relative ischemia during or after enteral feeding,41–43 or the presence 
of a hemodynamically significant patent ductus arteriosus (hsPDA).44 All of these 
factors have been suggested previously to increase the risk of the development of 
necrotizing enterocolitis. Two days prior to the onset of necrotizing enterocolitis 
(at median postnatal day eight), we observed statistically significant higher values 
of intestinal FTOE in  infants who developed necrotizing enterocolitis compared 
with controls (Chapter 6). This finding suggests that impaired splanchnic perfu-
sion is present before the first clinical symptoms of necrotizing enterocolitis occur. 
The impaired circulation on intestinal integrity does, however, not seem to induce 
direct damage of the intestinal cells, as we found no differences in iFABP/cru, ratios 
between subjects that developed necrotizing enterocolitis and controls in the week 
prior to the development of necrotizing enterocolitis (Chapter 3).
After the clinical suspicion of necrotizing enterocolitis had arisen, we clearly 
observed higher levels of iFABP/cru in necrotizing enterocolitis subjects compared 
to controls (Chapter 3). This is in line with previous data, also from our institution.45 
We therefore concluded that necrotizing enterocolitis is a disease in which intestinal 
damage and clinical signs go together. In the studies described in this thesis, we did 
not measure regional tissue oxygenation after the clinical suspicion of necrotizing 
enterocolitis. Data from another prospective trial in our center regarding the course 
of necrotizing enterocolitis (No-NEC-trial), however, showed a strong correlation 
between cerebral and splanchnic FTOE values with plasma iFABP levels during the 
first 16 hours after the onset of necrotizing enterocolitis.46 We speculate, then, that 
the elevated iFABP/cru ratios we found after the clinical suspicion of necrotizing 
enterocolitis also have been accompanied by higher cerebral and splanchnic FTOE 







or hypothesis is true. If so, the combination of cerebral and splanchnic FTOE values 
with iFABP levels in urine might aid in the noninvasive prediction of the progression 
of necrotizing enterocolitis.
An obvious risk factor for necrotizing enterocolitis that is directly related to 
prematurity is the immaturity of the immune defense together with an excessive 
inflammatory response.32 It is unknown whether the onset of necrotizing entero-
colitis is preceded by a low-grade inflammatory process that does not yet induce 
clinical signs. This inflammatory process might be accompanied by subclinical 
enterocyte damage. In the week prior to the onset of necrotizing enterocolitis, we 
found no differences in fecal calprotectin levels between infants who went on to 
develop necrotizing enterocolitis and controls (Chapter 4). Neither did we observe 
differences in  iFABP/cru ratios between the two groups (Chapter 3). These find-
ings suggest that there is no subclinical inflammatory process and accompanying 
enterocyte damage prior to the onset of necrotizing enterocolitis. We did find, 
however, high concentrations and wide interindividual variation in calprotectin 
levels in  our study population when compared to calprotectin concentrations 
in  children and adults. These high concentrations may reflect increased trans-
epithelial migration of neutrophils into the intestinal lumen as a result of higher 
intestinal permeability during the neonatal period.22,47,48 Even so, this higher per-
meability does not seem to be related to the development of necrotizing enteroco-
litis later on, as concentrations of calprotectin were comparable in infants who did 
not develop the disease.
Another risk factor of the development of necrotizing enterocolitis might 
be the level of fecal bile salts. Intra-luminal accumulation of fecal bile salt levels 
can result in intestinal epithelial destruction. This epithelial damage is similar to 
histopathological findings in  necrotizing enterocolitis.35 In  the first feces sample 
after birth i.e. at the 3rd postnatal day, we found no differences in both composition 
and concentration of fecal bile salt levels between infants who went on to develop 
necrotizing enterocolitis and infants who did not (controls). We observed, however, 
a  slower decrease of total unconjugated fecal bile salt concentrations in  subjects 
that developed necrotizing enterocolitis between birth and the onset of the disease 
when compared to controls. In the week prior to the development of necrotizing 
enterocolitis, total unconjugated bile salts were higher in infants developing necro-
tizing enterocolitis compared with levels measured in controls.
In line with previous studies we speculate that this transient failure to 
decrease bile salts coincides with an increased level of intra-enteric bile salts of the 
preterm intestine, predisposing an infant to the development of necrotizing entero-
colitis. This leaves the question: how can increased levels of fecal bile salts be related 
to increased levels of intra-enterocyte bile salts? One answer to this question is that 
intracellular intestinal bile salts have been shown to decrease ileal mucin produc-
tion and alter the intestinal mucus layer which might compromise the intestinal 
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barriers function.49 Another possibility is involvement of apical sodium dependent 
bile acid transporter (ASBT), a protein involved in the luminal uptake of bile salts 
into the enterocyte.29,50 Necrotizing enterocolitis was attenuated in ASBT knockout 
mice and in rats treated with an ASBT inhibitor.50 In according with the postulated 
role of increased bile-salt uptake at the distal small intestine, ASBT expression was 
increased in  intestinal samples of preterm infants with necrotizing enterocolitis, 
compared with ileal surgical samples from preterm infants with other diseases.50 
Interestingly, it has recently been suggested that the expression of ASBT is influenced 
by the intestinal microbiota.29 Under physiological circumstances, the microbiota 
causes a suppression of ASBT expression, limiting the expression of this transporter 
to the terminal ileum. An alteration of the intestinal microbiota, as a result of, for 
instance, antibiotic treatment or formula feeding, might lead to a change in ASBT 
expression and hence to increased levels of intra-enterocyte bile salts. Whether the 
course of fecal bile salts in preterm infants is influenced by antibiotic treatment or 
type of feeding is unknown, just as it is unclear whether this course of bile salts is 
related to the microbiota, iFABP levels or circulatory measurement.
In conclusion, the results of this thesis confirm the prevailing idea that pre-
term necrotizing enterocolitis is a multifactorial disease. Those infants who develop 
necrotizing enterocolitis do so because they have acquired multiple distinct risk 
factors. The direct effect of these factors on  intestinal integrity seems relatively 
mild since enterocyte damage is not detectable prior to the first clinical signs of 
the disease. The first ‘hit’ (e.g. a  reduction of intestinal circulation) might occur 
even before birth, or during the first days after birth and predispose an infant to the 
development of necrotizing enterocolitis later in life. When this first hit is followed 
by multiple distinct factors that have additive risk, such as anemia and the pres-
ence of an hsPDA that impair the intestinal circulation or antibiotic treatment and 
formula feeding that might affect the levels of bile salts, the preterm infant might go 
on to develop necrotizing enterocolitis. The coincidence of risk factors seems to be 
an acute event, in which damage of the intestinal cells rapidly leads to clinical signs.
Future perspectives
The markers we described in this thesis were all investigated separately for their role 
in the identification of infants who are most likely to develop necrotizing entero-
colitis. It would be very interesting and of added value to determine the potential 
predictive power of combining these different markers.
We mentioned that measuring cerebral and splanchnic oxygenations might 
be useful in the early identification of preterm infants who will develop necrotiz-
ing enterocolitis. The results were, however, found in a relatively small number of 







usefulness of monitoring cerebral and splanchnic oxygenation values to predict the 
onset of necrotizing enterocolitis needs to be investigated further in a larger, prefer-
ably multi-center, trial. Until data of such a trial becomes available, we suggest that 
infants with low cerebral oxygenation saturation within the first two days after birth 
should be monitored more intensively in order to notify the first clinical signs of 
necrotizing enterocolitis as early as possible.
Although no specific change in  the intestinal microbiota has been impli-
cated in necrotizing enterocolitis so far, disturbance of the colonization patterns 
in the developing intestine is thought to play a role in the pathophysiology of the 
disease.11,51 Recent advances in 16S rRNA based sequencing technologies allow for 
detailed analysis of the bacterial composition of feces, including the accurate mea-
surement of unculturable bacteria.52–54 Further studies are needed to determine the 
composition of the intestinal microbiota in  preterm neonates and its relation to 
the development of necrotizing enterocolitis later on.  Early microbial signatures 
in both feces and urine should also be studied, as they might provide highly predic-
tive biomarkers of necrotizing enterocolitis.51
Both an altered microbiota and formula feeding are thought to influence 
the levels of fecal bile salts.28,29 As we found higher levels of fecal bile salts prior to 
the development of necrotizing enterocolitis, it would be very interesting to inves-
tigate the precise effect of the microbiota, antibiotic treatment and type of feeding 
on levels of fecal bile salts in preterm infants, and determine their role in the patho-
physiology of necrotizing enterocolitis.
Studies on non-invasive markers in the prediction of necrotizing entero-
colitis remain essential in  the near future. These studies should, however, go 
together with studies regarding the unraveling of the pathophysiology of necro-
tizing enterocolitis. The more we understand the pathophysiology of this devastat-
ing disease, the better we will be able to strike out preventative strategies, which 
may subsequently improve neonatal outcome. Prevention of this highly damaging 
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